PLUSME: Application for Convalescent Plasma Donor Based on Digital Database for COVID-19 Patient Treatment

This application can run if it has the support of all IRC and hospitals in Indonesia. With the integration of convalescent plasma availability data at IRC with the application, it will be easier for the public to see the availability without having to bother coming directly to IRC.

1. Government

The government can help introduce the application to the public so that the public can use this application effectively to obtain blood plasma in an efficient and effective manner.

1. Public

The community can help introduce and recommend this application to others so that more people are helped.

1. COVID-19 Survivor Community

COVID-19 survivors can use this application as a means to donate blood. By using this application, COVID-19 survivors will make it easier for those who need convalescent blood donation.

 

Implementation Process

1. Requirement Analysis --- Conducting public research to analyze problems regarding increasing demand for convalescent plasma donors that imbalances its supplies. PLUSME features will be customized according to the analysis to create a suitable system that is needed by its future user.
2. System Design --- Designing an application operating system such as PLUSME user interface and its features.
3. Implementation --- Implementing analysis that is required by the system that has been aligned with application interface design. Features are created regarding user's requirements through developments to create an effective system.
4. System Testing --- Once the implementation step is completed, there will be testing to minimize the number of errors.
5. System Maintenance --- Maintain and develop features such as updating information and fix existing errors to support the application's sustainability

SWOT Analysis

PLUSME has strengths to facilitate the search for donors and the process of blood transfusion, provide checking services by partnering with accredited health institutions, availability of convalescent plasma donor feature, there are also consulting services at affordable prices for who wants to become either a donor or recipient. Therefore. PLUSME also has some weaknesses such as low brand awareness and requires substantial capital. In order to overcome these problems, PLUSME will reach out to various stakeholders to increase brand awareness and raise capital, such as Hospitals, Universities, Health Offices, etc. Meanwhile, PLUSME has opportunity to assists government's concentration in reducing COVID-19 cases in Indonesia while there are no similar applications with a focus on blood donation. PLUSME will also face a threat if once COVID-19 has already solved, demands for this application will be decreased. However, PLUSME will still be able to continuously provide developments in health service consultation.

Closing

COVID-19 has become the largest issue that needs to be overcome by Indonesia, especially when it comes to medical treatment for patients. Convalescent plasma donor has proven to be effective as an alternative to accelerate the recovery process. However, there's a gap between how many donors are required and the number of donors availability. Therefore, PLUSME is created to solve the problem by connecting the donors and recipients as well as creating a database for future potential donors. Working together with IRC, PLUSME is expected to provide the help that connects people and accelerates their recovery process from COVID-19 infection.

References